Abbott Receives FDA Approval For CREON
Originally posted in Cystic Fibrosis News From Medical News Today
Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON
No Comments »
RSS feed for comments on this post. TrackBack URL
by Raelene
